Manufacturer
Boehringer Ingelheim Pharmaceuticals
Pharmaceutical manufacturer based in Germany
Germany
- Products listed
- 55
- Molecules
- 20
- Therapy areas
- 7
Boehringer Ingelheim Pharmaceuticals is a pharmaceutical manufacturer based in Germany. MedsAcross lists 55 of its products across 20 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Germany
- Indian manufacturer
- No
- Also listed as
- Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Boehringer Ingelheim Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Diabetes
18 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Glyxambi 10 mg/5 mg tabletOral | Empagliflozin and Linagliptin | US FDA | Available on request |
| Glyxambi 25 mg/5 mg tabletOral | Empagliflozin and Linagliptin | US FDA | Available on request |
| Jardiance 10 mg tabletOral | Empagliflozin | US FDA | Available on request |
| Jardiance 25 mg tabletOral | Empagliflozin | US FDA | Available on request |
| Jentadueto 2.5 mg/1000 mg tabletOral | Linagliptin and Metformin | US FDA | Available on request |
| Jentadueto 2.5 mg/500 mg tabletOral | Linagliptin and Metformin | US FDA | Available on request |
| Jentadueto 2.5 mg/850 mg tabletOral | Linagliptin and Metformin | US FDA | Available on request |
| Jentadueto XR 2.5 mg/1000 mg extended-release tabletOral | Linagliptin and Metformin | US FDA | Available on request |
| Jentadueto XR 5 mg/1000 mg extended-release tabletOral | Linagliptin and Metformin | US FDA | Available on request |
| Synjardy 12.5 mg/1000 mg tabletOral | Empagliflozin and Metformin | US FDA | Available on request |
| Synjardy 12.5 mg/500 mg tabletOral | Empagliflozin and Metformin | US FDA | Available on request |
| Synjardy 5 mg/1000 mg tabletOral | Empagliflozin and Metformin | US FDA | Available on request |
| Synjardy 5 mg/500 mg tabletOral | Empagliflozin and Metformin | US FDA | Available on request |
| Synjardy XR 10 mg/1000 mg extended-release tabletOral | Empagliflozin and Metformin | US FDA | Available on request |
| Synjardy XR 12.5 mg/1000 mg extended-release tabletOral | Empagliflozin and Metformin | US FDA | Available on request |
| Synjardy XR 25 mg/1000 mg extended-release tabletOral | Empagliflozin and Metformin | US FDA | Available on request |
| Synjardy XR 5 mg/1000 mg extended-release tabletOral | Empagliflozin and Metformin | US FDA | Available on request |
| Tradjenta 5 mg tabletOral | Linagliptin | US FDA | Available on request |
Haematology
9 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Pradaxa 110 mg oral pelletsOral | Dabigatran | US FDA | Available on request |
| Pradaxa 110 mg capsuleOral | Dabigatran | US FDA | Available on request |
| Pradaxa 150 mg capsuleOral | Dabigatran | US FDA | Available on request |
| Pradaxa 150 mg oral pelletsOral | Dabigatran | US FDA | Available on request |
| Pradaxa 20 mg oral pelletsOral | Dabigatran | US FDA | Available on request |
| Pradaxa 30 mg oral pelletsOral | Dabigatran | US FDA | Available on request |
| Pradaxa 40 mg oral pelletsOral | Dabigatran | US FDA | Available on request |
| Pradaxa 50 mg oral pelletsOral | Dabigatran | US FDA | Available on request |
| Pradaxa 75 mg capsuleOral | Dabigatran | US FDA | Available on request |
Immunology and transplant
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Adalimumab kit Cold chainGeneric name | Adalimumab | US FDA | Available on request |
| Cyltezo kit Cold chain | Adalimumab | US FDA | Available on request |
| Jascayd 18 mg tabletOral | Nerandomilast | US FDA | Available on request |
| Jascayd 9 mg tabletOral | Nerandomilast | US FDA | Available on request |
| Spevigo 150 mg injectionIntravenous Cold chain | Spesolimab | US FDA | Available on request |
| Spevigo 300 mg injectionIntravenous Cold chain | Spesolimab | US FDA | Available on request |
| Spevigo 450 mg/7.5 mL injectionIntravenous Cold chain | Spesolimab | US FDA | Available on request |
Oncology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Gilotrif 20 mg tabletOral | Afatinib | US FDA | Available on request |
| Gilotrif 30 mg tabletOral | Afatinib | US FDA | Available on request |
| Gilotrif 40 mg tabletOral | Afatinib | US FDA | Available on request |
| Ofev 100 mg capsuleOral | Nintedanib | US FDA | Available on request |
| Ofev 150 mg capsuleOral | Nintedanib | US FDA | Available on request |
Respiratory
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Spiriva HandiHaler 18 mcg inhalation capsuleInhalation, oral | Tiotropium | US FDA | Available on request |
| Spiriva Respimat 1.562 mcg sprayInhalation | Tiotropium | US FDA | Available on request |
| Spiriva Respimat 3.124 mcg sprayInhalation | Tiotropium | US FDA | Available on request |
| Striverdi Respimat 2.5 mcg sprayInhalation | Olodaterol | US FDA | Available on request |
Cardiology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Micardis HCT 12.5 mg/40 mg tabletOral | Hydrochlorothiazide and Telmisartan | US FDA | Available on request |
| Micardis HCT 12.5 mg/80 mg tabletOral | Hydrochlorothiazide and Telmisartan | US FDA | Available on request |
| Micardis HCT 25 mg/80 mg tabletOral | Hydrochlorothiazide and Telmisartan | US FDA | Available on request |
Antidotes
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Praxbind 2500 mg/50 mL injectionIntravenous Cold chain | Idarucizumab | US FDA | Available on request |
Other products
8 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Atrovent HFA 17 mcg inhalerInhalation | Ipratropium | US FDA | Available on request |
| Combivent Respimat 100 mcg/20 mcg sprayInhalation | Albuterol and Ipratropium | US FDA | Available on request |
| Hernexeos 60 mg tabletOral | Zongertinib | US FDA | Available on request |
| Stiolto Respimat 2.736 mcg/3.124 mcg sprayInhalation | Olodaterol and Tiotropium | US FDA | Available on request |
| Trijardy XR 10 mg/5 mg/1000 mg extended-release tabletOral | Empagliflozin, Linagliptin and Metformin | US FDA | Available on request |
| Trijardy XR 12.5 mg/2.5 mg/1000 mg extended-release tabletOral | Empagliflozin, Linagliptin and Metformin | US FDA | Available on request |
| Trijardy XR 25 mg/5 mg/1000 mg extended-release tabletOral | Empagliflozin, Linagliptin and Metformin | US FDA | Available on request |
| Trijardy XR 5 mg/2.5 mg/1000 mg extended-release tabletOral | Empagliflozin, Linagliptin and Metformin | US FDA | Available on request |
Molecules made
AdalimumabIpratropiumAlbuterol and IpratropiumAfatinibEmpagliflozin and LinagliptinZongertinibEmpagliflozinNerandomilastLinagliptin and MetforminHydrochlorothiazide and TelmisartanNintedanibDabigatranIdarucizumabSpesolimabTiotropiumOlodaterol and TiotropiumOlodaterolEmpagliflozin and MetforminLinagliptinEmpagliflozin, Linagliptin and Metformin
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Boehringer Ingelheim Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.